TY - JOUR
T1 - Enhancing effects of carbon tetrachloride in mouse hepatocarcinogenesis
AU - Dragani, Tommaso A.
AU - Manenti, Giacomo
AU - Della Porta, Giuseppe
PY - 1986
Y1 - 1986
N2 - The enhancing effects of 4 or 8 necrogenic doses of carbon tetrachloride (CCl4) on hepatocarcinogenesis were studied in female B6C3F1 mice previously treated with a single dose of N-nitroso-N-diethylamine (NDEA) at 7 days of age. The CCl4 treatments were given every other week and started either after weaning or at 18-26 weeks of age, and the animals were observed until 36 weeks of age. The number and size of hepatocellular nodules were then scored and analysed. Hepatocellular nodules were not observed in mice receiving either 4 or 8 CCl4 treatments without NDEA initiation. Both 4 and 8 CCl4 treatments promoted NDEA-initiated hepatocarcinogenesis, increasing nodule size but not nodule frequency. Eight CCl4 doses were more effective than 4 and gave the greatest increase in nodule size when administered from 18 to 32 weeks of age. In an additional experiment, 3 mice bearing hepatocellular nodules induced by a single infantile NDEA treatment were administered CCl4 once and killed 52 h later. Nine neoplastic nodules were examined and found to be resistant to the CCl4 induced necrosis, although cells in the nodules were actively dividing at the same rate as in the regenerating surrounding normal liver parenchyma. The ability of a few necrogenic CCl4 doses to enhance hepatocarcinogenesis may be related to a differential cytotoxicity on neoplastic and normal hepatocytes and to a similar mitogenic stimulus on both cell types.
AB - The enhancing effects of 4 or 8 necrogenic doses of carbon tetrachloride (CCl4) on hepatocarcinogenesis were studied in female B6C3F1 mice previously treated with a single dose of N-nitroso-N-diethylamine (NDEA) at 7 days of age. The CCl4 treatments were given every other week and started either after weaning or at 18-26 weeks of age, and the animals were observed until 36 weeks of age. The number and size of hepatocellular nodules were then scored and analysed. Hepatocellular nodules were not observed in mice receiving either 4 or 8 CCl4 treatments without NDEA initiation. Both 4 and 8 CCl4 treatments promoted NDEA-initiated hepatocarcinogenesis, increasing nodule size but not nodule frequency. Eight CCl4 doses were more effective than 4 and gave the greatest increase in nodule size when administered from 18 to 32 weeks of age. In an additional experiment, 3 mice bearing hepatocellular nodules induced by a single infantile NDEA treatment were administered CCl4 once and killed 52 h later. Nine neoplastic nodules were examined and found to be resistant to the CCl4 induced necrosis, although cells in the nodules were actively dividing at the same rate as in the regenerating surrounding normal liver parenchyma. The ability of a few necrogenic CCl4 doses to enhance hepatocarcinogenesis may be related to a differential cytotoxicity on neoplastic and normal hepatocytes and to a similar mitogenic stimulus on both cell types.
UR - http://www.scopus.com/inward/record.url?scp=0022518213&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022518213&partnerID=8YFLogxK
U2 - 10.1016/0304-3835(86)90008-X
DO - 10.1016/0304-3835(86)90008-X
M3 - Article
C2 - 3697961
AN - SCOPUS:0022518213
VL - 31
SP - 171
EP - 179
JO - Cancer Letters
JF - Cancer Letters
SN - 0304-3835
IS - 2
ER -